Jun 1, 2026 01:53PM
Jun 1, 2026 01:51PM
May 21, 2026 04:28PM
May 20, 2026 02:18PM
May 19, 2026 08:30PM
May 19, 2026 08:30PM
May 19, 2026 02:16PM ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
May 19, 2026 07:31AM
May 19, 2026 07:30AM
May 18, 2026 01:01PM
May 18, 2026 07:31AM
May 18, 2026 07:30AM
May 16, 2026 01:35PM
May 16, 2026 01:35PM ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
May 7, 2026 09:00AM
May 7, 2026 07:30AM
Apr 6, 2026 07:30AM
Apr 6, 2026 07:30AM
Mar 31, 2026 07:31AM
Mar 31, 2026 07:30AM
Mar 26, 2026 07:30AM ImmunityBio bladder cancer trial meets statistical power requirements
Mar 26, 2026 07:30AM
Mar 24, 2026 12:52PM
Mar 24, 2026 10:44AM
Mar 24, 2026 09:27AM
Mar 20, 2026 01:08PM
Mar 20, 2026 01:08PM
Mar 17, 2026 07:31AM NCCN updates bladder cancer guidelines to include ImmunityBio's ANKTIVA
Mar 17, 2026 07:30AM
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM
Mar 4, 2026 07:54AM
Feb 26, 2026 07:31AM
Feb 26, 2026 07:30AM
Feb 23, 2026 04:15PM ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation "Cancer 2035: A Roadmap for the Future" Summit
Feb 23, 2026 09:36AM
Feb 23, 2026 07:01AM
Feb 23, 2026 07:00AM
Feb 20, 2026 08:30AM
Feb 20, 2026 08:30AM
Feb 19, 2026 09:02AM
Feb 19, 2026 09:00AM ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch
Feb 18, 2026 09:01AM
Feb 18, 2026 09:00AM
Feb 17, 2026 06:09AM
Feb 17, 2026 06:07AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas
Jan 26, 2026 06:49AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All